Home » Newsletters » BioWorld Science

BioWorld Science

May 25, 2010

View Archived Issues

AGN-203818 useful to reduce hypersensitivity in heartburn and IBS patients

Acute rejection rates similar with CP-690550 and ciclosporin in renal transplant patients

Pfizer identifies new fatty-acid amide hydrolase inhibitors

Ranolazine exhibits antifibrillatory activity during severe coronary stenosis

Phase II data in cystic fibrosis disclosed on TR-02

Clinical safety and pharmacokinetic data of inhaled liposomal ciprofloxacin reported

Comparable safety/efficacy/tolerability of ilaprazole and esomeprazole in duodenal ulcer

Increased IGFBP-7 expression reduces breast cancer growth

Lundbeck reports highlights of first quarter 2010

NeuroTherapeutics closes series B financing to advance pipeline

Vagifem 10-mcg tablets replace 25-mcg formulation for atrophic vaginitis

Anadys reports on phase II combination trial of ANA-598

AndroScience and Orient Europharma collaborate on topical acne therapy

Bayer Schering Pharma claims new MEK 1 inhibitors

Janssen describes new serotonin receptor ligands

Ligand acquires milestone and royalty interest in MEDI-528 for asthma

New mGlu5 receptor antagonists claimed by GlaxoSmithKline

Sorrento Therapeutics receives NIH grant for innovative MRSA infection program

Grifols acquires Pharmalink's post-polio syndrome drug development project

NORD awards Shire for developing VPRIV in Gaucher's disease

Elagolix meets all efficacy endpoints in phase II trial in endometriosis

FDA extends review period of FTY-720 in relapsing MS

New data on coadministration of Intuniv and stimulants in ADHD

Enrollment complete in phase II brentuximab vedotin trial in ALCL

Phase III data reported on clobazam in Lennox-Gastaut syndrome

Intercell honored for developing IC-51 Japanese encephalitis vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...